Trial Profile
Efficacy and safety of tolvaptan in acute decompensated heart failure - ESTATE-HF
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 Nov 2019
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary) ; Heart failure therapies
- Indications Acute heart failure
- Focus Therapeutic Use
- Acronyms ESTATE-HF
- 09 Jul 2013 New trial record